Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Lv, Chaoyang ^a   Chen, Minling ^a,b   Xu, Ming ^a   Xu, Guiping ^a,c   Zhang, Yao ^a   He, Shunmei ^a   Xue, Mengjuan ^a   Gao, Jian ^a   Yu, Mingxiang ^a   Gao, Xin ^a   Zhu, Tongyu ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; GLUCOSE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; GLUCOSE BLOOD LEVEL; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BODY MASS; CADAVER KIDNEY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; ADVERSE EFFECTS; CAUSE OF DEATH; DIET RESTRICTION; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; RISK FACTOR;

ADULT; BLOOD GLUCOSE; CAUSE OF DEATH; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84902595044     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099406     Document Type: Article

References (60)

1. Huang J (2007) Ethical and legislative perspectives on liver transplantation in the People's Republic of China. Am J Transplant 13: 193-196.
2. Hanto DW (2008) Ethics committee oversight of living related donor kidney transplantation in China. Am J Transplant 8: 1765-1766.
3. Aktas A (2014) Transplanted kidney function evaluation. Semin Nucl Med 44: 129-145.
4. D'Addio F, Vergani A, Di Fenza R, Tezza S, Bassi R, et al. (2012) Novel immunological aspects of pediatric kidney transplantation. G Ital Nefrol 29: 44-48.
5. Del Carro U, Fiorina P, Amadio S, De Toni Franceschini L, Petrelli A, et al. (2007) Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis. Diabetes Care 30: 3063-3069. (Pubitemid 350255247)
6. Orsenigo E, Socci C, Fiorina P, Cristallo M, Castoldi R, et al. (2004) Simultaneous pancreas-kidney transplantation: short- and long-term results. Transplant Proc 36: 568-588.
7. Davidson J, Wilkinson A, Dantal J (2003) New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 75: SS3-SS24.
8. Folli F, Guzzi V, Perego L, Coletta DK, Finzi G, et al. (2010) Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. Plos one 5: e9923.
9. Fiorina P, Vezzull P, Bassi R, Gremizzi C, Falautano M, et al. (2012) Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care 35: 367-374.
10. Salonia A, D'Addio F, Gremizzi C, Briganti A, Deho F, et al. (2011) Kidney-pancreas transplantation is associated with near-normal sexual function in uremic type 1 diabetic patients. Transplantation 92: 802-808.
11. Orsenigo E, Socci C, Fiorina P, Zuber V, Secchi A, et al. (2005) Cardiovascular benefits of simultaneous pancreas-kidney transplant versus kidney alone transplant in diabetic patients. Transplant Proc 37: 3570-3571. (Pubitemid 41659956)
12. Fiorina P, Folli F, D'Angelo A, Finzi G, Pellegatta F, et al. (2004) Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes 53: 2291-2300. (Pubitemid 39145582)
13. Valderhaug TG, Hjelmesaeth J, Hartmann A, Roislien J, Bergrem HA, et al. (2011) The association of early post-transplant glucose levels with long-term mortality. Diabetologia 54: 1341-1349.
14. Fiorina P, Bassi R, Gremizzi C, Vergani A, Caldara R, et al. (2012) 31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients. Acta Diabetol 49: 133-139.
15. Fiorina P, Perseghin G, De Cobelli F, Gremizzi C, Petrelli A, et al. (2007) Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation. Diabetes Care 30: 597-603. (Pubitemid 46354340)
16. Fiorina P, Venturini M, Folli F, Losio C, Maffi P, et al. (2005) Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care 28: 1303-1310. (Pubitemid 40756688)
17. Ducloux D, Kazory A, Chalopin JM (2005) Post-transplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 79: 438-443. (Pubitemid 40280176)
18. Astorri E, Fiorina P, Gavaruzzi G, Astorri A, Magnati G (1997) Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment. Cardiology 88: 152-155. (Pubitemid 27105669)
19. Perseghin G, Fiorina P, De Cobelli F, Scifo P, Esposito A, et al. (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46: 1085-1092. (Pubitemid 41316519)
20. Hecking M, Werzowa J, Haidinger M, Horl WH, Pascual J, et al. (2013) Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant 28: 1-15.
21. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003) A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant 18: 2154-2159. (Pubitemid 37220325)
22. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, et al. (2005) Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 19: 291-298. (Pubitemid 40711959)
23. Amer Diabet, Assoc (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30: S42-S47.
24. Wyzgal J, Paczek L, Sanko-Resmer J, Ciszek M, Nowak M, et al. (2007) Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann Transplant 12: 26-29.
25. Brzezinska B, Junik R, Kaminska A, Wlodarczyk Z, Adamowicz A (2013) Factors associated with glucose metabolism disorder after kidney transplantation. Endokrynol Pol 64: 21-25.
26. Xu Y, Liang JX, Liu B, Yao B, Pokharel S, et al. (2011) Prevalence and long-term glucose metabolism evolution of post-transplant diabetes mellitus in Chinese renal recipients. Diabetes Res Clin Pract 92: 11-18.
27. Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, et al. (2007) Risk factors associated with the onset and progress of post transplantation diabetes in renal allograft recipients. Diabetes care 30: 609-615.
28. Marin M, Renoult E, Bondor CI, Kessler M (2005) Factors influencing the onset of diabetes mellitus after kidney transplantation: A single french center experience. Transplant Proc 37: 1851-1856. (Pubitemid 40790849)
29. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel EK, et al. (2002) Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25: 583-592.
30. Luan FL, Steffick DE, Ojo AO (2011) New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation 91: 334-341.
31. Knight SR, Morris PJ (2010) Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A Meta-Analysis. Transplantation 89: 1-14.
32. Fernandez LA, Lehmann R, Luzi L, Battezzati A, Angelico MC, et al. (1999) The effects of maintenance doses of FK506 versus Cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 68: 1532-1541.
33. Maffi P, Bertuzzi F, De Taddeo F, Magistretti P, Nano R, et al. (2007) Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progressive of diabetic nephropathy. Diabetes Care 30: 1150-1155. (Pubitemid 46684640)
34. Ozbay LA, Smidt K, Mortensen DM, Carstens J, Jorgensen KA, et al. (2011) Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J pharmacol 162: 136-146.
35. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, et al. (2006) Calcineurin/NFAT signaling regulates pancreastic bata-cell growth and function. Nature 443: 345-349. (Pubitemid 44435154)
36. Polastri L, Galbiati F, Bertuzzi F, Fiorina P, Nano R, et al. (2002) Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol 39: 229-233. (Pubitemid 35470538)
37. Neumayer HH, Farber L, Haller P, Kohnen R, Maibucher A, et al. (1996) Substitution of conventional cyclosporine with a new microemusion formulation in renal transplant patients: result after 1 year. Nephrol Dial Transplant 11: 165-172. (Pubitemid 26038483)
38. Mathew JT, Rao M, Job V, Ratnaswamy S, Jacob CK (2003) Post-transplant hyperglycaemia: a study of risk factors. Nephrol Dial Transplant 18: 164-171. (Pubitemid 36104494)
39. Cotovio M, Neves L, Rodrigues R, Alves R, Bastos M, et al. (2013) New-onset diabetes after transplantations: assessment of risk factors and clinical outcomes. Transplant Proc 45: 1079-1083.
40. Duijnhoven EM, Boots JM, Christiaans MH, Wolffenbuttel BH, Van Hooff JP (2001) Influence of tacrolimus on glucose metabolism before and after transplantation: a prospective study. J Am Soc Nephrol 12: 583-588. (Pubitemid 32180028)
41. Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, et al. (1995) Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 59: 1606-1613.
42. Davidson JA, Wilkinson A (2004) New-onset diabetes after transplantation 2003 international consensus guidelines - An endocrinologist's view. Diabetes Care 27: 805-812. (Pubitemid 38280557)
43. Borda B, Lengyel C, Szederkenyi E, Eller J, Keresztes, et al. (2012) Post-transplantation diabetes mellitus-Risk factors and effects on the function and morphology of the allograft. Acta Physiol Hung 99: 206-215.
44. Luan FL, Zhang H, Schaubel DE, Miles CD, Cibrik D, et al. (2008) Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late post-transplant period. Am J Transplant 8: 1871-1877.
45. Teutonico A, Schena PF, Di Paolo S (2005) Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 16: 3128-3135. (Pubitemid 44743511)
46. Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, et al. (2010) Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant 25: 985-992.
47. Maldonado F, Tapia G, Ardiles L (2009) Early Hyperglycemia: A risk factor for posttransplant diabetes mellitus among renal transplant recipients. Transplant Proc 41: 2664-2667.
48. Kuo HT, Poommipanit N, Sampaio M, Reddy P, Cho YW, et al. (2010) Risk factors for development of New-Onset Diabetes Mellitus in pediatric renal transplant recipients: an analysis of the OPTN/UNOS Database. Transplantation 89: 434-439.
49. Baid-Agrawal S, Frei U, Reinke P, Schindler R, Kopp MA, et al. (2009) Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients. Am J Transplant 9: 2777-2784.
50. Zelle DM, Corpeleijn E, VanRee RM, Stolk RP, van der Veer E, et al. (2010) Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipient. Am J Transplant 10: 106-114.
51. Neetha S, Biju T, Amita R (2008) Comparison of neutrophil function in diabetic and healthy subjects with chronic generalized periodontitis. J Indian Soc Periodontol 12: 41-44.
52. Luan FL, Langewisch E, Ojo A (2010) Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients. Clin Transplant 24: 778-783.
53. Porrini E, Delgado P, Bigo C, Alvarez A, Cobo M, et al. (2006) Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 48: 134-142.
54. Wiesbauer F, Heinze G, Regele H, Horl WH, Schernthaner GH, et al. (2010) Glucose control is associated with patient survival in diabetic patients after Renal transplantation. Transplantation 89: 612-619.
55. Sezer S, Akgul A, Altunoglu A, Arat Z, Ozdemir FN, et al. (2012) Posttransplantation diabetes mellitus: Impact of blood glucose regulation on renal transplant recipient outcome. Transplant Proc 44: 2893-2893.
56. Orsenigo E, Fiorina P, Cristallo M, Scocci C, La Rocca E, et al. (2004) Long-term survival after kidney and kidney-pancreas transplantation in diabetic patients. Transplant Proc 36: 1072-1075. (Pubitemid 38766278)
57. Elmagd MM, Bakr MA, Metwally AH, Wahab AM (2008) Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant. Exp Clin Transplant 6: 42-47. (Pubitemid 351983975)
58. Huang T, Ren J, Huang J, Li D (2013) Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach. BMC Genomics 14: 1471-2164.
59. Paroni R, Fermo I, Fiorina P, Cighetti G (2005) Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects. Amino acids 28: 389-394. (Pubitemid 40884729)
60. Cighetti G, Fermo I, Aman CS, Ferraroni M, Secchi A, et al. (2009) Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress. Free Radic Biol Med 47: 307-311.